医療従事者の為の最新医療ニュースや様々な情報・ツールを提供する医療総合サイト

Leading Chinese Research Institute Purchases Provantis Preclinical Software Solution for Shanghai Headquarters

2014年11月06日 PM11:30
このエントリーをはてなブックマークに追加


 

CONSHOHOCKEN, Pa.

Instem, a leading provider of IT solutions to the global early development healthcare market, is pleased to announce that the Shanghai Institute of Planned Parenthood Research (National Evaluation Centre for the Toxicology of Fertility Regulating Drugs) (SIPPR-NTC) has purchased the Provantis Reproductive Toxicology software solution to automate processes at its Shanghai facility.

Founded in 1978, SIPPR-NTC is recognized as a center of excellence in the area of reproductive health and is one of the major collaborating centers of the World Health Organization’s HRP program. HRP is the main instrument within the United Nations system for research in human reproduction, bringing together policy-makers, scientists, health care providers, clinicians, consumers and community representatives to identify and address priorities for research to improve reproductive health.

SIPPR-NTC’s investment in Provantis will further streamline its research processes and will deliver increased efficiencies in the collection, storage and reporting of key research data.

Key Facts

  • Provantis Reproductive Toxicology module purchased by SIPPR-NTC for their Shanghai facility
  • Contract awarded following a formal competitive tender; Provantis recognized as the overwhelming standard within China and the leading solution around the world
  • Instem to implement a full turnkey solution, including hardware and software deployment
  • SIPPR has purchased a range of professional services to facilitate quicker implementation and faster return on investment

Dr. Zu-Yue Sun, Director, SIPPR-NTC, said “We are delighted to be deploying Instem’s world-leading Provantis software solution at our Shanghai facility. SIPPR-NTC has exciting growth plans for the future and we see our partnership with Instem and our investment in Provantis as a key component of our growth strategy.”

Neil Donaldson, VP Sales Europe & Asia, Instem commented “We are extremely pleased to welcome SIPPR-NTC to our Provantis user community. SIPPR-NTC is recognized as a leading organization within their field and it is a great honor that they have chosen Instem to support them in their growth plans.”

About SIPPR-NTC

SIPPR-NTC is a principal member of the Shanghai Life Science Research Center, a national resource institute for fertility regulating studies, and one of the largest World Health Organization collaborating centers in the Asia Pacific region. With continuous support from the Government, World Health Organization, and UNFPA, SIPPR has developed into a comprehensive research center at a national level, as well as an international collaborating resource for human reproductive health. SIPPR has successfully conducted many key national projects and international research programs.

To learn more about SIPPR please visit http://www.sippr.org.cn/eng.php/Eng/article/detailPage/parentID/1313/cat_id/1251

http://www.ntc-who.org/

About Instem

Instem is a leading supplier of IT applications to the early development healthcare market, delivering compelling solutions for data collection, management and analysis across the R&D continuum. Instem applications are in use by customers worldwide, meeting the rapidly expanding needs of life science and healthcare organizations for data-driven decision making leading to safer, more effective products.

Instem’s portfolio of software solutions increases client productivity by automating study-related processes while offering the unique ability to generate new knowledge through the extraction and harmonization of actionable scientific information.

Instem supports over 400 clients through full service offices in the United States, United Kingdom and China with additional locations in India and a full service distributor based in Japan.

To learn more about Instem solutions and its mission, please visit www.instem.com

Meeting clients at the intersection of investment & return™.

http://www.linkedin.com/company/instem/

https://www.facebook.com/Instem.software

https://twitter.com/Instemsoftware

CONTACT

Press Contacts:
Instem
Julie Jones (UK HQ)
+44
(0) 1785 825600
julie.jones@instem.com
or
Gary
Mitchell (US HQ)
610-941-0990
gary.mitchell@instem.com

Related Posts Plugin for WordPress, Blogger...
 

同じカテゴリーの記事 

  • BioVectra与Keryx Biopharmaceuticals签署枸橼酸铁扩产协议
  • Eternity Healthcare Inc. Enters into Share Exchange Agreement with Guizho Tongren Healthy China Biotechnology Co. Ltd.
  • Takeda and TiGenix announce that Cx601 (darvadstrocel) has received a positive CHMP opinion to treat complex perianal fistulas in Crohn’s disease
  • Chi-Med Initiates Fruquintinib U.S. Clinical Trials
  • Orthocell Granted European Tendon Regeneration Patent